Medtronic (MDT) Tops Q4 EPS by 8c, Offers FY22 Guidance, Raises Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Medtronic, Inc. (MDT) PT Raised to $147 at Oppenheimer
May 28, 2021 9:50 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Medtronic, Inc. (NYSE: MDT) to $147.00 (from $134.00) while maintaining an Outperform rating following fourth quarter results.
The analyst commented, "On its F4Q21 call, MDT highlighted continued COVID-19 procedural recovery and solid sales outlook. Key updates: 1) monthly... More
Medtronic (MDT) Tops Q4 Earnings Estimates, Announces 'Largest Ever' R&D Spending to Support Growth
May 27, 2021 10:20 AM EDTShares of Medtronic (NYSE: MDT) are up 0.5% in todays trading session after the company reported better-than-expected earnings for its fourth quarter.
The company reported adjusted earnings per share (EPS) of $1.50 per share on $8.19 billion in sales, which compares to EPS of $1.42 a share on $7.86 billion in sales expected from the surveyed market analysts.
"We reported a strong end to our fiscal year, with our fourth quarter results demonstrating continued momentum. Our recovery improved throughout the quarter, with most of our markets returning to near normal, pre-COVID... More
